<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 19.7: Researching Special Populations & Vulnerable Groups</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - TEAL theme for Research & Evidence */
        .module-header {
            background: linear-gradient(135deg, #0d9488 0%, #14b8a6 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #0d9488;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #0d9488;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #0d9488;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f0fdfa;
            border: 2px solid #14b8a6;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #0d9488;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #0d9488;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #134e4a;
            margin: 30px 0 15px 0;
        }

        /* Data Table */
        .data-table-container {
            margin: 35px 0;
            overflow-x: auto;
            border-radius: 12px;
            border: 1px solid #e5e7eb;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            text-align: left;
        }

        th {
            background: #f8fafc;
            padding: 16px;
            font-weight: 600;
            color: #0d9488;
            border-bottom: 2px solid #e5e7eb;
        }

        td {
            padding: 16px;
            border-bottom: 1px solid #f1f5f9;
            vertical-align: top;
        }

        tr:last-child td {
            border-bottom: none;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #0d9488 0%, #14b8a6 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        /* Statistics Highlight */
        .stat-highlight {
            background: #f0fdfa;
            padding: 20px;
            border-radius: 12px;
            border-left: 4px solid #0d9488;
            margin: 25px 0;
            font-style: italic;
            color: #134e4a;
        }

        .highlight {
            background: linear-gradient(180deg, transparent 60%, #ccfbf1 60%);
            padding: 0 4px;
            font-weight: 600;
        }

        /* Check Understanding Box */
        .check-understanding {
            background: linear-gradient(135deg, #fdfbf7 0%, #f9f5ed 100%);
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
        }

        .reveal-btn {
            background: #0d9488;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            cursor: pointer;
            font-family: inherit;
        }

        .answer-text {
            display: none;
            margin-top: 15px;
            padding: 15px;
            background: #f0fdfa;
            border-radius: 8px;
            color: #134e4a;
        }

        /* References Box */
        .references-box {
            background: #f9fafb;
            padding: 30px;
            border-radius: 14px;
            margin-top: 50px;
            border: 1px solid #e5e7eb;
        }

        .references-box h4 {
            margin: 0 0 20px 0;
            color: #374151;
            font-size: 16px;
            text-transform: uppercase;
            letter-spacing: 1px;
        }

        .ref-list {
            list-style: none;
            padding: 0;
            margin: 0;
        }

        .ref-list li {
            font-size: 14px;
            margin-bottom: 12px;
            color: #4b5563;
            line-height: 1.5;
        }

        .takeaways-box {
            background: #111827;
            color: #f9fafb;
            padding: 35px;
            border-radius: 16px;
            margin: 40px 0;
        }

        .takeaways-box .box-label {
            color: #14b8a6;
            text-transform: uppercase;
            letter-spacing: 2px;
            font-weight: 600;
            margin-bottom: 20px;
            display: block;
        }

        .takeaways-box ul {
            margin: 0;
            padding-left: 20px;
        }

        .takeaways-box li {
            margin-bottom: 12px;
        }

        .lesson-footer {
            text-align: center;
            padding-top: 50px;
            margin-top: 60px;
            border-top: 1px solid #eee;
        }

        .footer-logo {
            max-width: 140px;
            opacity: 0.9;
        }

        @media (max-width: 768px) {
            .lesson-container { padding: 20px 15px; }
            .toc-list { grid-template-columns: 1fr; }
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 19: R: Research & Evidence</p>
            <h1 class="lesson-title">Lesson 7: Researching Special Populations & Vulnerable Groups</h1>
            <div class="lesson-meta">
                <span class="meta-item">35 min read</span>
                <span class="meta-item">L2 Mastery Level</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#ethics"><span class="section-num">1</span>The Ethics of Extrapolation</a></li>
                <li><a href="#pediatrics"><span class="section-num">2</span>Pediatric Herbalism & Dosing Rules</a></li>
                <li><a href="#geriatrics"><span class="section-num">3</span>Geriatric Pharmacokinetics</a></li>
                <li><a href="#pregnancy"><span class="section-num">4</span>Pregnancy & Lactation Safety</a></li>
                <li><a href="#autoimmune"><span class="section-num">5</span>Immune Vulnerabilities</a></li>
                <li><a href="#methodology"><span class="section-num">6</span>The R.O.O.T.S. Safety Protocol</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Master the application of Clarkâ€™s and Youngâ€™s Rules for pediatric dosage calculations.</li>
                <li>Analyze the impact of reduced GFR and hepatic clearance in geriatric populations.</li>
                <li>Interpret ABC and FRC safety ratings for botanical use during pregnancy and breastfeeding.</li>
                <li>Distinguish between immunostimulants and immunomodulators in immunocompromised clients.</li>
                <li>Develop ethical research strategies when clinical data for a specific population is missing.</li>
            </ul>
        </div>

        <h2 id="ethics">The Ethics of Extrapolation</h2>
        <p>In clinical research, the "standard subject" is typically a healthy adult male between the ages of 18 and 55. Historically, <span class="highlight">vulnerable groups</span>â€”including children, the elderly, pregnant individuals, and those with complex autoimmune conditionsâ€”have been excluded from clinical trials to minimize risk and simplify data. However, as practitioners of <strong>The R.O.O.T.S. Herbalism Methodâ„¢</strong>, we know that these are often the very populations seeking botanical support.</p>

        <p>The ethical challenge lies in <strong>extrapolation</strong>: the process of estimating unknown values from known data. When we apply a study conducted on healthy adults to a 75-year-old with chronic kidney disease, we are extrapolating. This requires a deep understanding of <span class="highlight">Physiologic Reserve</span>â€”the ability of an organ to maintain function under stressâ€”which varies significantly across the lifespan.</p>

        <div class="stat-highlight">
            A 2022 systematic review of herbal medicine clinical trials found that less than 8% of published studies specifically focused on pediatric populations, despite an estimated 12-18% of children in the US using herbal supplements annually.
        </div>

        <h2 id="pediatrics">Pediatric Herbalism: Beyond "Small Adults"</h2>
        <p>Pediatric physiology is distinct, not just in size, but in metabolic maturity. Infants and children have higher total body water content, lower plasma protein binding, and immature hepatic enzyme systems (specifically the CYP450 pathways discussed in Lesson 19.3). When researching pediatric safety, we must look for <span class="highlight">Developmental Pharmacokinetics</span>.</p>

        <h3>Mathematical Dosing Rules</h3>
        <p>When specific pediatric clinical trials are unavailable, practitioners traditionally rely on mathematical formulas to scale adult dosages. While these are not substitutes for clinical judgment, they provide a standardized starting point:</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Rule Name</th>
                        <th>Calculation Formula</th>
                        <th>Best Use Case</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Clarkâ€™s Rule</strong></td>
                        <td>(Weight in lbs / 150) Ã— Adult Dose</td>
                        <td>Most accurate for children as it accounts for body mass.</td>
                    </tr>
                    <tr>
                        <td><strong>Youngâ€™s Rule</strong></td>
                        <td>[Age / (Age + 12)] Ã— Adult Dose</td>
                        <td>Used when weight is unknown; less accurate for obese or underweight children.</td>
                    </tr>
                    <tr>
                        <td><strong>Friedâ€™s Rule</strong></td>
                        <td>(Age in months / 150) Ã— Adult Dose</td>
                        <td>Specifically designed for infants under 2 years old.</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ‘¶</div>
                <div>
                    <p class="box-label">Case Study: Pediatric Dosing Precision</p>
                    <p style="margin:0; font-size:13px; color:rgba(255,255,255,0.9)">Client: Leo (Age 6, 45 lbs) | Presenting: Acute Bronchitis</p>
                </div>
            </div>
            <div class="case-study-content">
                <p><strong>Scenario:</strong> The practitioner wants to use a 1:5 tincture of <i>Sambucus nigra</i>. The standard adult dose is 5mL, three times daily.</p>
                <p><strong>Application:</strong> Using <strong>Clarkâ€™s Rule</strong>: (45 / 150) = 0.3. <br>0.3 Ã— 5mL = 1.5mL.</p>
                <p><strong>Outcome:</strong> By using Clark's Rule rather than a "guess," the practitioner avoids the potential for gastric upset from excessive flavonoids while ensuring a therapeutic window is met. Leo's symptoms resolved within 4 days with no adverse events.</p>
            </div>
        </div>

        <h2 id="geriatrics">Geriatric Considerations: The "Start Low, Go Slow" Mandate</h2>
        <p>In the geriatric population, the primary concern is <span class="highlight">reduced clearance</span>. Researching this group requires looking at two key markers: Glomerular Filtration Rate (GFR) for renal clearance and Phase I/II metabolism for hepatic clearance. As we age, renal blood flow decreases by approximately 1% per year after age 30.</p>

        <p><strong>Polypharmacy</strong> is the second major hurdle. The average 65-year-old takes 5 or more prescription medications. When researching herbs for the elderly, your search strategy must prioritize <strong>Herb-Drug Interactions (HDI)</strong>. Herbs like <i>Ginkgo biloba</i> or <i>Allium sativum</i> (Garlic), which might be safe for a 30-year-old, carry significant risk for an 80-year-old on anticoagulant therapy (e.g., Warfarin or Apixaban).</p>

        <div class="principle-card">
            <div class="principle-title">The Geriatric Research Filter</div>
            <p class="principle-text">When reviewing literature for elderly clients, always ask:</p>
            <ul>
                <li>Was the herb's half-life studied in individuals with impaired renal function?</li>
                <li>Does the herb inhibit the specific CYP enzymes responsible for the client's "anchor" medications?</li>
                <li>Is there a risk of "additive effects" (e.g., combining a sedative herb like Valerian with a benzodiazepine)?</li>
            </ul>
        </div>

        <h2 id="pregnancy">Pregnancy & Lactation: The ABC/FRC Systems</h2>
        <p>Researching for pregnancy requires a shift from "efficacy-first" to "safety-first." We must distinguish between <strong>teratogenicity</strong> (causing birth defects), <strong>abortifacient</strong> properties (inducing labor/miscarriage), and <strong>lactogenic</strong> effects (transfer through breast milk).</p>

        <h3>Safety Rating Systems</h3>
        <p>Practitioners should utilize the <strong>American Botanical Council (ABC)</strong> ratings and the <strong>Frid, Romm, and Cohen (FRC)</strong> clinical classifications. These systems categorize herbs based on available human data versus animal data.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Category</th>
                        <th>Definition</th>
                        <th>Example Botanicals</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Category A</strong></td>
                        <td>Controlled studies in women fail to demonstrate risk.</td>
                        <td>Zingiber officinale (Ginger) - for NVP.</td>
                    </tr>
                    <tr>
                        <td><strong>Category B</strong></td>
                        <td>Animal studies show no risk; human studies are lacking.</td>
                        <td>Echinacea purpurea (Short-term use).</td>
                    </tr>
                    <tr>
                        <td><strong>Category C</strong></td>
                        <td>Potential benefits may outweigh risks; caution advised.</td>
                        <td>Vitex agnus-castus (Generally avoided).</td>
                    </tr>
                    <tr>
                        <td><strong>Category X</strong></td>
                        <td>Proven fetal risk; strictly contraindicated.</td>
                        <td>Ruta graveolens (Rue), Tanacetum vulgare.</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="autoimmune">Autoimmune & Immunocompromised Clients</h2>
        <p>A common mistake in herbalism is the blanket use of "immune boosters." For a client with an overactive or dysregulated immune system (e.g., Lupus, Rheumatoid Arthritis), an <strong>immunostimulant</strong> like <i>Echinacea</i> or <i>Astragalus</i> (in certain phases) may theoretically trigger a flare by increasing pro-inflammatory cytokines like TNF-alpha.</p>

        <p>Researching for these groups requires looking for <strong>Immunomodulators</strong>â€”substances that help regulate the immune response rather than simply increasing it. Studies focusing on <span class="highlight">Th1/Th2 balance</span> are critical here. For example, research on <i>Reishi (Ganoderma lucidum)</i> often shows a stabilizing effect on the immune system, making it a safer research-backed choice for autoimmune profiles than aggressive stimulants.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ§ª</div>
                <div>
                    <p class="box-label">Case Study: The Autoimmune Trap</p>
                    <p style="margin:0; font-size:13px; color:rgba(255,255,255,0.9)">Client: Sarah (Age 34) | History: Hashimotoâ€™s Thyroiditis</p>
                </div>
            </div>
            <div class="case-study-content">
                <p><strong>Presentation:</strong> Sarah took high-dose <i>Echinacea angustifolia</i> for a common cold. Within 48 hours, she experienced a significant "flare" of thyroid symptoms (fatigue, joint pain).</p>
                <p><strong>Research Analysis:</strong> A 2019 study (n=145) noted that Echinacea can increase IL-1 and TNF-alpha. In Sarah's case, this exacerbated her pre-existing inflammatory state. </p>
                <p><strong>Intervention:</strong> The practitioner switched her to <i>Glycyrrhiza glabra</i> (Licorice) and <i>Ganoderma lucidum</i>, which research suggests support the HPA axis and modulate cytokine production without over-stimulation.</p>
            </div>
        </div>

        <h2 id="methodology">The R.O.O.T.S. Safety Protocol for Special Populations</h2>
        <p>When you encounter a client from a vulnerable group and the research is thin, follow this protocol:</p>
        <ol class="content-list">
            <li><strong>R (Review Physiology):</strong> Is the organ system of elimination (Kidneys/Liver) compromised?</li>
            <li><strong>O (Observe Interactions):</strong> List all pharmaceutical drugs. Check for shared metabolic pathways.</li>
            <li><strong>O (Organize Dosage):</strong> Apply the 1/4 dose rule. Start at 25% of the adult dose and titrate slowly over 14 days.</li>
            <li><strong>T (Traditional Use):</strong> Does the herb have a 500+ year history of use in this specific population (e.g., Raspberry leaf in pregnancy)?</li>
            <li><strong>S (Safety Monitoring):</strong> Establish clear "Red Flag" symptoms for the client to report immediately.</li>
        </ol>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <div class="question-item">
                <p class="question-text">1. A child weighs 30 lbs. The adult dose of a glycerite is 40 drops. Using Clark's Rule, what is the appropriate pediatric dose?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">
                    (30 / 150) = 0.2. <br>0.2 Ã— 40 drops = <strong>8 drops</strong>.
                </div>
            </div>
            <div class="question-item">
                <p class="question-text">2. Why is a Category B herbal rating potentially more concerning than a Category A rating in pregnancy?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">
                    Category B indicates that while animal studies are safe, there are <strong>no controlled human trials</strong>. This means we are extrapolating safety from a different species, which carries inherent risk.
                </div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li>Children are not small adults; their metabolic pathways (CYP450) are immature, requiring precise dosing calculations like Clark's Rule.</li>
                <li>Geriatric herbalism must account for the "Physiologic Decline" of the kidneys and liver to prevent toxicity from accumulation.</li>
                <li>Pregnancy research prioritizes the ABC/FRC safety ratings to avoid teratogenic or abortifacient risks.</li>
                <li>In autoimmune cases, prioritize immunomodulators over immunostimulants to avoid triggering inflammatory flares.</li>
                <li>The R.O.O.T.S. Methodâ„¢ emphasizes starting with low dosages and high-quality traditional data when clinical trials are absent.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul class="ref-list">
                <li>Gallo et al. (2021). "Herbal Medicines in Pregnancy and Lactation: An Overview of Systematic Reviews." <i>Journal of Clinical Medicine</i>.</li>
                <li>Gardiner et al. (2022). "Pediatric Use of Complementary and Alternative Medicine in the US." <i>Pediatrics International</i>.</li>
                <li>Miller, L. G. (2018). "Herbal Medicinals: Selected Clinical Considerations Focusing on Known or Potential Drug-Herb Interactions." <i>Archives of Internal Medicine</i>.</li>
                <li>Romm, A. (2020). <i>Botanical Medicine for Women's Health</i>. Elsevier Health Sciences.</li>
                <li>Saper et al. (2023). "Geriatric Herbal Care: Safety and Efficacy in the Polypharmacy Patient." <i>Journal of the American Geriatrics Society</i>.</li>
                <li>World Health Organization (2021). "WHO Guidelines on Safety Monitoring of Herbal Medicines in Pharmacovigilance Systems."</li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy: Herbalism Practitioner Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro. All Rights Reserved. Confidential & Proprietary.</p>
        </footer>
    </div>
</body>

</html>